Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Saskatoon
Clinical trial register · Canada

Clinical Trials in Saskatoon, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Canada and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6553 matching records held by the registry are in this view. Synced 10 Nov 2026, 03:20 UTC
6553
Studies in scope
all four open statuses
3487
Recruiting now
open to new participants
880
Lead sponsors
across recruiting studies
Top sites
Toronto 2818 Montreal 1913 Vancouver 1187 Calgary 1068 Edmonton 1018
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
University of Saskatchewan19 NRG Oncology7 Janssen Research & Development, LLC5 AstraZeneca4 Merck Sharp & Dohme LLC4 Incyte Corporation4 University of Calgary3 Ottawa Hospital Research Institute3 AbbVie3 Hoffmann-La Roche3 McMaster University2 Inmagene LLC2 Alliance for Clinical Trials in Oncology2 Amgen2 Bayer2 Novartis Pharmaceuticals2 The Hospital for Sick Children2 University of British Columbia2 Sanofi2 Pfizer2 Sunnybrook Health Sciences Centre1 Centre Hospitalier Universitaire de Besancon1 University of Manitoba1 Arrowhead Pharmaceuticals1 MediciNova1 Boehringer Ingelheim1 OncoC4, Inc.1 Centre hospitalier de l'Université de Montréal (CHUM)1 Spyre Therapeutics, Inc.1 Canadian Myeloma Research Group1 University Health Network, Toronto1 NoNO Inc.1 Relay Therapeutics, Inc.1 Apollo Therapeutics Ltd1 Zura Bio Inc1 ImmunoVaccine Technologies, Inc. (IMV Inc.)1 OncoVerity, Inc.1 University of Waterloo1 European Myeloma Network B.V.1 LEO Pharma1 GlaxoSmithKline1 United Therapeutics1 Loxo Oncology, Inc.1 University of North Carolina, Chapel Hill1 Chronicle Academy1 National Cancer Institute (NCI)1 Cara Spence1 Genentech, Inc.1 Coultreon Biopharma1 Dr. John A. Thiel Medical Professional Corporation1 UCB Biopharma SRL1 Indiana Hemophilia &Thrombosis Center, Inc.1 Medical University of South Carolina1 Leiden University Medical Center1 University of Alberta1 SWOG Cancer Research Network1 European Organisation for Research and Treatment of Cancer - EORTC1 Celgene1 Genmab1 Canadian Cancer Trials Group1 Daiichi Sankyo1 Galderma R&D1 Target PharmaSolutions, Inc.1 Takeda1 London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's1 Australasian Gastro-Intestinal Trials Group1 Seagen, a wholly owned subsidiary of Pfizer1 argenx1 Alexion Pharmaceuticals, Inc.1 Bluefin Biomedicine, Inc.1
Site location
Toronto2818 Montreal1913 Vancouver1187 Calgary1068 Edmonton1018 Ottawa884 London878 Hamilton811 Québec682 Halifax535 Winnipeg454 Sherbrooke264 Kingston254 Kelowna176 Brampton143 Surrey138 Victoria129 St. John's126 Barrie125 Saskatoon125 Chicoutimi100 Moncton92 Mississauga89 Greater Sudbury83 Regina82 Trois-Rivières80 Saint John75 Greenfield Park73 Oshawa73 New Westminster70 Newmarket68 North York64 Markham61 Ajax60 Windsor55 Lévis53 Kitchener49 Fredericton49 Oakville48 Waterloo47 Guelph42 Rimouski39 Burlington37 Peterborough37 Abbotsford British Columbia36 Sarnia34 Red Deer33 Scarborough Village32 Laval30 Cambridge30 Richmond Hill30 Etobicoke26 Vaughan26 Thunder Bay26 Gatineau24 Prince George22 Sault Ste. Marie21 North Vancouver20 Richmond20 Burnaby19 Sherwood Park18 Lethbridge18 Verdun18 Whitby17 Niagara Falls17 North Bay17 Sydney16 St. Catharines14 Stouffville13 Saint-Jérôme13 Saint-Charles-Borromée13 Longueuil13 Stoney Creek12 Concord11 Kentville11 Truro10 Terrebonne10 Penticton10 Courtice9 Mount Royal9 Kamloops9 Mirabel8 Victoriaville8 St. Albert7 Saint Catharines7 Winchester7 Joliette6 Brandon6 Dartmouth6 West Vancouver6 Bridgewater6 Saguenay6 Medicine Hat6 Thornhill6 Brantford5 Pointe-Claire5 Orillia5 Westmount5 Cobourg5 East York5 Nanaimo5 Ontario5 Nova Scotia4 Owen Sound4 Chilliwack4 Montral4 North YORK4 Scarborough4 Boisbriand4 Multiple Locations4 Woodbridge4 Granby4 Langley4 Sainte-Foy4 New Minas3 Canmore3 Dieppe3 Ste-Foy3 Decarie Montreal3 Many Locations3 Grande Prairie3 Winnepeg3 Chatham2 Stratford2 Belleville2 Nepean2 Saint Johns2 Saint-Georges2 Fort McMurray2 Cranbrook2 Hawkesbury2 Dundas2 Sainte-Marie2 Okanagan2 SaintJerome2 Pembroke2 Pierrefonds2 Bedford2 Alberta2 Banff2 Jonquière2 Saint-Laurent2 Edmundston2 Montréal2 Niagara2 Hanover1 Renfrew1 Drummondville1 Maria1 Miramichi1 Penetanguishene1 Norway House1 Baie-Saint-Paul1 La Malbaie1 Edmonton & Calgary1 Multiple1 North Van Couver1 Grand Prairie1 Mississagua1 Saint Isidore1 Bowmanville1 Coxheath1 Lai Chi Kok1 Sioux Lookout1 Wawa1 Piikani Nation1 Flying Dust First Nation1 Ministikwan Lake1 Onion Lake1 Waterhen Lake1 Greenville1 Fleurimont1 Saint Catherines1 Prince Albert1 Calgery1 Frederiction1 Vancouver BC1 Prince Rupert1 Sept-Îles1 Ville-Marie1 Orangeville1 Whistler1 Egypt1 Port Perry1 Newcastle1 Mira Road1 Happy Valley-Goose Bay1 Norris Point1 Woodstock1 High River1 Antigonish Nova Scotia1 Saint Jerome Quebec1 Airdrie1 Burin1 Clarenville1 Hailfax1 Alliston1 Cowansville1 Saint-Hyacinthe1 Montr Al1 Kanata1 Pickering1 Columbia1 Charlottetown1 Dalhousie1 Carbonear1 Cornwall1 Limoges1 Orléans1 Aurora1 Mission1 Dorchester1 Smiths Crossing1 Moose Jaw1 Fort Erie1 Kelowna BC1 Coburg1 Tiny1 Ganges1 Bathurst1 Bouctouche1 Campbellton1 Caraquet1 Grand Falls1 Saint-Quentin1 Pierrefonds-Roxboro1 Edmonton AB1 Montréal1 Châteauguay1 Portage la Prairie1 Denver1 Winnipeg MB1 Brockville1 Montreal, Quebec1 Weston1 Gloucester1 Emo1 Dryden1 Fort Frances1 Lakefield1 Napanee1 Hamitlon1 Laurier1 Hagersville1 Strathroy1 West Hamilton1 Don Mills1 Val-d'Or1
All 248 locations
Target enrolment
to

Trials with a site in Saskatoon

125 of 6553 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Canada
Start
Not yet open
Coultreon Biopharma
Phase 2
100
Markham, Mississauga, Peterborough, Québec, Richmond Hill, Saskatoon
2026-10-31
Not yet open
University of Manitoba
Not applicable
90
Edmonton, Winnipeg, Saskatoon
2026-09-23
Recruiting
Spyre Therapeutics, Inc.
Phase 2
150
Edmonton, Surrey, Winnipeg, Barrie, Markham, Richmond Hill, Québec, Saskatoon
2026-09
Not yet open
University of Saskatchewan
Not applicable
10
Saskatoon
2026-08-17
Recruiting
Prospective Evaluation of an AI Diagnostic Ultrasound Tool for Fetal Weight Estimation
NCT07661433Fetal Weight, Pregnancy, Machine Learning, Pregnancy - Prenatal Testing
University of North Carolina, Chapel Hill
Not applicable
1,000
Saskatoon
2026-06-29
By invitation
Inmagene LLC
Phase 2
400
Surrey, Vancouver, Greater Sudbury, Mississauga, North Bay, Montreal, Saskatoon
2026-06-05
By invitation
CHOICE+ Quality Improvement for Long Term Care Homes
NCT07505407Long Term Care Homes, Malnutrition Elderly, Malnutrition Risk in Elder
University of Waterloo
Observational
800
Winnipeg, Antigonish Nova Scotia, Waterloo, Saskatoon
2026-06-01
Recruiting
Bayer
Phase 3
117
Edmonton, Vancouver, London, Toronto, Montreal, Saskatoon
2026-06-01
Recruiting
A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
NCT07599813Atopic Dermatitis, Atopic, Dermatitis, Dermatitis, Atopic
Apollo Therapeutics Ltd
Phase 2
280
Calgary, Edmonton, Mississauga, Toronto, Sherbrooke, Saskatoon
2026-05-28
Recruiting
University of Saskatchewan
Not applicable
40
Saskatoon
2026-05-26
Recruiting
University of Saskatchewan
Not applicable
40
Saskatoon
2026-05-25
Recruiting
Arrowhead Pharmaceuticals
Phase 2
36
Vancouver, Calgary, Edmonton, Hamilton, Québec, Saskatoon
2026-03-30
Recruiting
Incyte Corporation
Phase 3
700
Edmonton, Hamilton, Toronto, Greenfield Park, Lévis, Saint-Jérôme, Saskatoon
2026-03-05
Recruiting
University of Saskatchewan
Not applicable
30
Saskatoon
2026-02-26
Recruiting
Ottawa Hospital Research Institute
Phase 4
50
Kitchener, Ottawa, Saskatoon
2026-02-02
Recruiting
University of British Columbia
Not applicable
232
Kelowna, Vancouver, Victoria, Kingston, Ottawa, Saskatoon
2026-01-12
Recruiting
Sanofi
Phase 2
144
Winnipeg, Mississauga, Richmond Hill, Toronto, Montreal, Sherbrooke, Regina, Saskatoon
2025-12-29
Active, closed
Boehringer Ingelheim
Phase 3
135
Edmonton, Vancouver, Toronto, Saskatoon
2025-12-09
Recruiting
Chronicle Academy
Observational
80
Burlington, Hamilton, Kanata, Ottawa, Pickering, Saskatoon
2025-11-25
Recruiting
Bayer
Phase 3
111
Edmonton, Vancouver, London, Toronto, Montreal, Saskatoon
2025-11-19
Active, closed
Takeda
Phase 2
207
Fredericton, Barrie, Hamilton, Oakville, Peterborough, Toronto, Québec, Saskatoon
2025-11-03
Not yet open
Evaluation of the Safety and Efficacy of NeuroEPO in Subjects With Mild to Moderate Alzheimer's Disease
NCT07178678Mild Alzheimer's Disease, Moderate Alzheimer's Disease
University of Saskatchewan
Phase 2
90
Saskatoon
2025-11
Recruiting
Hoffmann-La Roche
Phase 3
600
Kelowna, Victoria, Barrie, Brampton, Ottawa, Montreal, Rimouski, Saskatoon
2025-10-24
Recruiting
HIV Prevention With PrEP Among People on Opioid Replacement Therapy
NCT07160075HIV - Human Immunodeficiency Virus
Cara Spence
Phase 4
350
Calgary, Regina, Saskatoon
2025-08-28
Recruiting
Relay Therapeutics, Inc.
Phase 3
540
Brampton, Ottawa, Toronto, Montreal, Saskatoon
2025-08-26
Recruiting
Alexion Pharmaceuticals, Inc.
Phase 3
6
Saskatoon
2025-08-11
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,000
Moncton, Toronto, Montreal, Saskatoon
2025-07-21
Active, closed
Bluefin Biomedicine, Inc.
Phase 2
225
Calgary, Edmonton, Mississauga, Richmond Hill, Montreal, Saskatoon
2025-07-15
Recruiting
GlaxoSmithKline
Phase 3
981
Richmond, Ajax, Toronto, Windsor, Saint-Charles-Borromée, Sherbrooke, Saskatoon
2025-06-20
Recruiting
AbbVie
Phase 2
180
Calgary, Sherbrooke, Saskatoon
2025-06-20
Recruiting
Inmagene LLC
Phase 2
405
Surrey, Vancouver, Greater Sudbury, Mississauga, North Bay, Montreal, Saskatoon
2025-06-17
Active, closed
Incyte Corporation
Phase 3
573
Edmonton, Winnipeg, Fredericton, Hamilton, London, Markham, Mississauga, Saskatoon
2025-06-12
Not yet open
Dr. John A. Thiel Medical Professional Corporation
Not applicable
54
Saskatoon
2025-06-01
Recruiting
University of Saskatchewan
Not applicable
150
Saskatoon
2025-05-30
Active, closed
Zura Bio Inc
Phase 2
247
Newmarket, North York, Richmond Hill, Québec, Saskatoon
2025-05-16
Recruiting
Systemic Therapy With a Loco-regional Treatment in Patients With Locally Advanced Pancreatic Cancer
NCT04276857Locally Advanced Pancreatic Cancer, Irreversible Electroporation
University of Saskatchewan
Not applicable
27
Regina, Saskatoon
2025-05-01
Recruiting
Stretching to Improve Jumping Performance
NCT06944652Vertical Jump Performance
University of Saskatchewan
Not applicable
40
Saskatoon
2025-04-28
Recruiting
Pasteurized Donor Human Milk for HIV-Exposed Infants: A Pilot Study
NCT06955715HIV, Pregnancy, Breastfeeding, Infant Feeding Practices
University of Saskatchewan
Not applicable
10
Saskatoon
2025-04-15
Recruiting
AbbVie
Phase 2
300
Sherbrooke, Trois-Rivières, Saskatoon
2025-04-11
Recruiting
Feasibility of a Diet Intervention for Juvenile Arthritis
NCT06474546Arthritis, Juvenile, Arthritis, Childhood, Juvenile Idiopathic Arthritis
The Hospital for Sick Children
Not applicable
54
Winnipeg, Hamilton, London, Ottawa, Toronto, Montreal, Saskatoon
2025-04-07
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,000
Edmonton, Oshawa, Toronto, Chicoutimi, Montreal, Québec, Saskatoon
2025-03-16
Recruiting
UCB Biopharma SRL
Phase 3
40
Calgary, Montreal, Saskatoon
2025-03-11
Recruiting
Loxo Oncology, Inc.
Phase 2
249
Barrie, Saskatoon
2025-01-03
Not yet open
University of Saskatchewan
Phase 4
10
Saskatoon
2025-01-01
Active, closed
Daiichi Sankyo
Phase 3
700
London, Montreal, Ottawa, Saskatoon, Toronto
2024-11-19
Recruiting
University of Saskatchewan
Phase 1
20
Saskatoon
2024-10-26
Recruiting
Australasian Gastro-Intestinal Trials Group
Phase 2
78
Edmonton, Vancouver, London, Ottawa, Toronto, Regina, Saskatoon
2024-10-14
Active, closed
Incyte Corporation
Phase 3
346
Edmonton, Barrie, London, Toronto, Québec, Saskatoon
2024-10-10
Recruiting
NoNO Inc.
Phase 2
600
Calgary, Edmonton, Vancouver, Winnipeg, Hamilton, Ottawa, Toronto, Saskatoon
2024-10-02
Recruiting
University of Saskatchewan
Not applicable
99
Saskatoon
2024-09-01
Recruiting
AstraZeneca
Phase 3
788
Toronto, Greenfield Park, Montreal, Saskatoon
2024-08-01
Active, closed
OncoVerity, Inc.
Phase 2
140
Calgary, Edmonton, Vancouver, London, Ottawa, Toronto, Saskatoon
2024-07-22
Recruiting
Amgen
Phase 3
450
Calgary, Brampton, Toronto, Regina, Saskatoon
2024-07-17
Recruiting
Ottawa Hospital Research Institute
Not applicable
420
Hamilton, Kingston, Ottawa, Toronto, Québec, Saskatoon
2024-07-16
Recruiting
Canadian Cancer Trials Group
Phase 3
250
Vancouver, Winnipeg, St. John's, London, Ottawa, Montreal, Regina, Saskatoon
2024-06-26
Recruiting
LEO Pharma
Phase 3
195
Burlington, Calgary, Edmonton, Hamilton, Niagara Falls, Saskatoon, Windsor, Winnipeg
2024-06-10
Recruiting
Canadian Bone Strength Development Study
NCT06287840Type-1 Diabetes
University of Saskatchewan
Observational
204
Saskatoon
2024-04-01
Not yet open
University of Saskatchewan
Phase 3
200
Regina, Saskatoon
2024-02-29
Active, closed
Novartis Pharmaceuticals
Phase 3
1,466
Victoria, Halifax, Oakville, Ottawa, Toronto, Montreal, Québec, Saskatoon
2024-02-28
Active, closed
Sanofi
Phase 3
260
Calgary, Toronto, Montreal, Saskatoon
2024-01-23
Active, closed
Janssen Research & Development, LLC
Phase 3
838
Calgary, Vancouver, Halifax, Hamilton, Toronto, Montreal, Saskatoon
2024-01-22
Recruiting
Effects of Probiotics in Amyotrophic Lateral Sclerosis-Frontotemporal Dementia Spectrum Disorder (ALS-FTDSD) Patients
NCT06051123ALSFTD, ALS (Amyotrophic Lateral Sclerosis), Frontal Temporal Dementia (FTD)
Centre hospitalier de l'Université de Montréal (CHUM)
Not applicable
150
Fredericton, Montreal, Saskatoon
2024-01-01
Active, closed
argenx
Observational
413
London, Montreal, Québec, Saskatoon
2023-11-29
Recruiting
AstraZeneca
Phase 3
625
Barrie, Hamilton, Toronto, Greenfield Park, Montreal, Québec, Regina, Saskatoon
2023-11-23
Recruiting
Amgen
Phase 3
750
Halifax, Toronto, Montreal, Regina, Saskatoon, Québec
2023-11-16
Recruiting
United Therapeutics
Phase 3
698
Vancouver, Ajax, Hamilton, Montreal, Québec, Sherbrooke, Saskatoon
2023-10-30
Active, closed
Janssen Research & Development, LLC
Phase 3
311
Edmonton, Markham, Peterborough, Richmond Hill, Montreal, Québec, Saskatoon
2023-10-12
Active, closed
Virtual Physical Activity Seated Exercise - Phase 2
NCT05724823Stroke, Chronic Stroke, Stroke, Ischemic, Stroke Hemorrhagic
University of British Columbia
Not applicable
100
Vancouver, Winnipeg, Halifax, London, Saskatoon
2023-10-11
Recruiting
University of Saskatchewan
Not applicable
100
Saskatoon
2023-09-17
Recruiting
The Hospital for Sick Children
Not applicable
93
Halifax, Hamilton, London, Ottawa, Toronto, Montreal, Saskatoon, Calgary
2023-08-05
Active, closed
OncoC4, Inc.
Phase 3
630
Kelowna, Regina, Saskatoon
2023-06-28
Active, closed
Genmab
Phase 3
900
Calgary, Vancouver, Brampton, Hamilton, Saskatoon
2023-02-08
Active, closed
AstraZeneca
Phase 3
1,350
Saint John, Brampton, Greater Sudbury, Kitchener, Newmarket, Montreal, Saint-Jérôme, Saskatoon
2022-12-29
Recruiting
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
400
Ottawa, Toronto, Montreal, Saskatoon
2022-10-24
Active, closed
Janssen Research & Development, LLC
Phase 3
418
New Westminster, Barrie, Saskatoon
2022-09-13
Recruiting
European Myeloma Network B.V.
Phase 3
1,594
Edmonton, Halifax, Ottawa, Saskatoon, Sherbrooke, Toronto, Vancouver
2022-09-08
Active, closed
Pfizer
Phase 2
108
Ottawa, Toronto, Saskatoon
2022-07-11
Active, closed
Testing the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in Patients With Metastatic Urothelial Cancer, MAIN-CAV Study
NCT05092958Advanced Bladder Urothelial Carcinoma, Advanced Renal Pelvis Urothelial Carcinoma, Advanced Ureter Urothelial Carcinoma, Advanced Urethral Urothelial Carcinoma
DrugsCabozantinib S-malate·Avelumab·Cabozantinib
National Cancer Institute (NCI)
Phase 3
654
Edmonton, Toronto, Regina, Saskatoon
2022-06-03
Active, closed
McMaster University
Not applicable
594
Winnipeg, Hamilton, Regina, Saskatoon
2022-06-01
Recruiting
Prebiotics in Patients With Type 1 Diabetes
NCT04963777Type 1 Diabetes
University of Calgary
Not applicable
144
Calgary, Edmonton, Saskatoon
2022-03-29
Recruiting
University of Saskatchewan
Not applicable
96
Saskatoon
2022-03-28
Active, closed
Novartis Pharmaceuticals
Phase 4
136
Edmonton, Burnaby, Vancouver, Granby, Lévis, Saskatoon
2022-03-02
Active, closed
University of Calgary
Not applicable
6,800
Winnipeg, St. John's, Halifax, Hamilton, London, Toronto, Montreal, Saskatoon
2022-02-09
Active, closed
Merck Sharp & Dohme LLC
Phase 3
280
Edmonton, Kelowna, Vancouver, Toronto, Montreal, Saskatoon
2022-02-03
Active, closed
Comparing Cisplatin Every Three Weeks to Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer
NCT05050162Advanced Head and Neck Squamous Cell Carcinoma, Advanced Hypopharyngeal Squamous Cell Carcinoma, Advanced Laryngeal Squamous Cell Carcinoma, Advanced Oropharyngeal Squamous Cell Carcinoma
DrugsCis-platinum·CDDP·Platinol-AQ·Cisplatin
NRG Oncology
Phase 2/3
475
Ottawa, Toronto, Montreal, Regina, Saskatoon
2022-02-01
Active, closed
Merck Sharp & Dohme LLC
Phase 3
643
Calgary, Abbotsford British Columbia, Victoria, Kingston, Toronto, Montreal, Québec, Saskatoon
2021-12-13
Active, closed
Canadian Myeloma Research Group
Phase 2
72
Edmonton, Halifax, Hamilton, Ottawa, Toronto, Regina, Saskatoon
2021-12-08
Recruiting
Leiden University Medical Center
Phase 3
316
Hamilton, Kelowna, Kingston, London, Montreal, Regina, Saint John, Saskatoon
2021-11-11
Recruiting
Pfizer
Phase 3
893
Calgary, Edmonton, Halifax, Hamilton, Toronto, Montreal, Saskatoon
2021-10-04
Recruiting
Ottawa Hospital Research Institute
Phase 4
500
Edmonton, Kitchener, London, Markham, Ottawa, Thunder Bay, Regina, Saskatoon
2021-08-19
Recruiting
NRG Oncology
Phase 3
1,670
Saint John, Kingston, Toronto, Montreal, Québec, Regina, Saskatoon
2021-06-23
Recruiting
ImmunoVaccine Technologies, Inc. (IMV Inc.)
Phase 2
102
Saskatoon
2021-06-18
Active, closed
Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking Ability
NCT04804644Metastatic Lung Small Cell Carcinoma, Metastatic Malignant Neoplasm in the Brain, Recurrent Lung Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8
NRG Oncology
Phase 3
152
Toronto, Québec, Regina, Saskatoon
2021-06-08
Recruiting
Non-Invasive Blood Pressure Monitoring
NCT05825937Blood Pressure
University of Saskatchewan
Observational
62
Saskatoon
2021-06-01
Active, closed
Incyte Corporation
Phase 3
899
Halifax, London, Montreal, Saskatoon, Sherbrooke
2021-05-11
Active, closed
T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial
NCT04457596Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, HER2 Positive Breast Carcinoma, Invasive Breast Carcinoma
DrugsTucatinib·Trastuzumab emtansine
Alliance for Clinical Trials in Oncology
Phase 3
1,056
Vancouver, Saint John, London, Oshawa, Toronto, Québec, Regina, Saskatoon
2021-03-02
Active, closed
NRG Oncology
Phase 3
2,753
Calgary, Ottawa, Toronto, Montreal, Québec, Sherbrooke, Regina, Saskatoon
2021-01-21
Active, closed
Galderma R&D
Phase 3
500
Calgary, London, North York, Saskatoon, Markham, Toronto
2021-01-11
Recruiting
Randomized Comparison of PARtial Wrist Fusion With or Without Triquetral Excision (PARTE)
NCT04580225Wrist Arthritis, Wrist Arthropathy, Scapholunate Advanced Collapse, Scaphoid Nonunion
University of Alberta
Not applicable
170
Calgary, St. Albert, London, Ottawa, Saskatoon
2021-01-07
Active, closed
ATG Plus PTCy vs ATG for CGVHD Prophylaxis
NCT04202835Acute Leukemia, Myelodysplasia, Chronic Graft-versus-host-disease
DrugsAnti-Thymocyte Globulin·Thymoglobulin·Cyclophosphamide
McMaster University
Phase 2
80
Winnipeg, Halifax, Hamilton, London, Québec, Saskatoon
2020-10-14
Recruiting
University of Calgary
Phase 3
440
Calgary, Edmonton, Halifax, Hamilton, Toronto, Montreal, Saskatoon
2020-07-14
Active, closed
MediciNova
Phase 2/3
234
Edmonton, Hamilton, Toronto, Montreal, Saskatoon, Québec
2020-05-28
Recruiting
University of Saskatchewan
Phase 1/2
14
Saskatoon
2020-02-01
Recruiting
Cognitive Outcomes After Dexmedetomidine Sedation in Cardiac Surgery Patients
NCT04289142Delirium, Cognitive Dysfunction, Cognition Disorder, Neurocognitive Disorders
Sunnybrook Health Sciences Centre
Phase 4
2,400
Vancouver, London, Toronto, Québec, Saskatoon
2019-12-01
Active, closed
Alliance for Clinical Trials in Oncology
Phase 3
242
Calgary, Edmonton, Hamilton, Toronto, Montreal, Québec, Saskatoon
2019-11-19
Active, closed
Janssen Research & Development, LLC
Phase 2/3
1,064
Vancouver, Winnipeg, Barrie, Toronto, Montreal, Saskatoon
2019-09-26
Active, closed
University Health Network, Toronto
Phase 1
40
Calgary, Toronto, Regina, Saskatoon
2019-09-20
Active, closed
Letrozole With or Without Paclitaxel and Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
NCT04095364Low Grade Fallopian Tube Serous Adenocarcinoma, Ovarian Low Grade Serous Adenocarcinoma, Primary Peritoneal Low Grade Serous Adenocarcinoma, Stage II Fallopian Tube Cancer AJCC v8
DrugsParaplatin·Taxol·Letrozole·Paclitaxel
NRG Oncology
Phase 3
450
Toronto, Montreal, Regina, Saskatoon
2019-09-20
Recruiting
Stroke Thrombectomy and Aneurysm Registry
NCT04994756Stroke, Thromboses, Intracranial, Aneurysm, Brain
Medical University of South Carolina
Observational
40,000
Saskatoon
2019-09-17
Active, closed
AbbVie
Phase 3
964
Victoria, Winnipeg, Peterborough, Waterloo, Sainte-Foy, Saskatoon
2019-03-25
Active, closed
Janssen Research & Development, LLC
Phase 3
765
Calgary, Vancouver, Victoria, Hamilton, Kingston, Toronto, Montreal, Saskatoon
2019-01-25
Active, closed
Celgene
Phase 3
363
Calgary, Edmonton, Hamilton, Ottawa, Toronto, Montreal, Saskatoon, Sherbrooke
2019-01-02
Active, closed
A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC
NCT03661866Atopic Dermatitis, Alopecia Areata, Hidradenitis Suppurativa, Vitiligo
Target PharmaSolutions, Inc.
Observational
15,000
Peterborough, Richmond Hill, Montreal, Saskatoon
2018-12-21
Recruiting
Study of Individuals Affected With Hypoplasminogenemia
NCT03797495Plasminogen Deficiency
Indiana Hemophilia &Thrombosis Center, Inc.
Observational
100
Windsor, Montreal, Québec, Saskatoon
2018-12-18
Active, closed
AstraZeneca
Phase 3
825
Edmonton, Kitchener, Lévis, Montreal, Québec, Saskatoon
2018-12-06
Active, closed
Hoffmann-La Roche
Phase 1/2
422
Hamilton, Montreal, Saskatoon
2018-09-25
Active, closed
Radiation Therapy With or Without Apalutamide in Treating Patients With Recurrent Prostate Cancer, the BALANCE Trial
NCT03371719Recurrent Prostate Carcinoma, Stage III Prostate Adenocarcinoma AJCC v7, Stage IV Prostate Adenocarcinoma AJCC v7
DrugApalutamide
NRG Oncology
Phase 2
298
Calgary, Toronto, Montreal, Québec, Sherbrooke, Regina, Saskatoon
2018-06-20
Active, closed
Hoffmann-La Roche
Phase 3
927
Burnaby, Vancouver, London, Toronto, Greenfield Park, Montreal, Saskatoon
2018-05-28
Active, closed
Centre Hospitalier Universitaire de Besancon
Not applicable
989
Montreal, Québec, Regina, Saskatoon, Sherbrooke, Vancouver, Winnipeg
2018-05-03
Active, closed
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase 1
30
Vancouver, London, Toronto, Montreal, Saskatoon
2018-01-19
Recruiting
University of Saskatchewan
Phase 4
62
Saskatoon
2017-09-01
Active, closed
SWOG Cancer Research Network
Phase 3
275
Edmonton, Hamilton, Ottawa, Toronto, Regina, Saskatoon
2015-12-29
Active, closed
NRG Oncology
Phase 2
624
Victoria, Ottawa, Windsor, Montreal, Québec, Saskatoon
2014-12-04
Active, closed
Genentech, Inc.
Phase 2
378
Kelowna, Ottawa, Saskatoon, Québec
2008-10-16
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
751
Calgary, London, Saskatoon, Toronto, Winnipeg
2007-12
Rows per page Showing 1–125 of 125
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Canadian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 November 2026. https://priyalifescience.com/clinical-trials-canada/city/saskatoon

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Canada and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,553 studies in total at the last sync on 10 Nov 2026, 03:20 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 125 of those studies with a site in Saskatoon.

How many clinical trials are recruiting in Saskatoon?

64 of the 125 studies on this page are recruiting new participants as of the 10 Nov 2026, 03:20 UTC sync. A further 7 have not yet opened recruitment, 52 are active but closed to new participants, and 2 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Saskatoon), 125 studies
PhaseStudiesRecruitingShare
Phase 3532342.4%
Not applicable251820%
Phase 2241119.2%
Observational856.4%
Phase 4755.6%
Phase 1312.4%
Phase 2/3302.4%
Phase 1/2211.6%

Most active sponsors

Lead sponsors with the most studies (Saskatoon)
Lead sponsorStudiesRecruiting
University of Saskatchewan1915
NRG Oncology71
Janssen Research & Development, LLC50
AstraZeneca42
Incyte Corporation41
Merck Sharp & Dohme LLC42
AbbVie32
Hoffmann-La Roche31
Ottawa Hospital Research Institute33
University of Calgary32
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.